Drugs.com: Pandemic disrupting lung cancer screening
January 5, 2021
Drugs.com reports that COVID-19 has caused significant disruption in lung cancer screening.
January 5, 2021
Drugs.com reports that COVID-19 has caused significant disruption in lung cancer screening.
January 21, 2021
UC research, published in JAMA Oncology, shows that chemotherapy before surgery for some pancreatic cancer patients may not improve survival rates.
March 8, 2021
Local 12 reports on a new study that could give pregnant women with addiction a new tool to deliver a healthy baby. Christine Wilder, MD, is interviewed.
March 16, 2021
Months after mammograms, colonoscopies and other routine cancer screenings, like lung cancer screenings, were suspended because of the pandemic, researchers are studying the impact.
December 4, 2020
UC researchers are seeking participants in a study for an opioid addiction treatment that could weaken withdrawal symptoms and increase the likelihood of recovery for pregnant women.
July 21, 2020
National media outlets report on new UC findings that show immunotherapy will not worsen complications for patients who have cancer and COVID-19.
September 22, 2020
Drugs.com covers UC research looking at mortality in patients with cancer and COVID-19.
September 22, 2020
WVXU reports on a University of Cincinnati study showing cancer patients undergoing a combination of chemotherapy and immunotherapy one to three months before a COVID-19 diagnosis have a greater risk of death than patients who haven't undergone cancer treatment in the past year.
August 6, 2020
During a pandemic, cancer is all the more terrifying, uncertain, and lonely. UC Cancer Center researchers weigh in.
June 30, 2023
A monthslong shortage of chemotherapies forces some patients to receive less treatment. University of Cincinnati Cancer Center's Davendra Sohal told the Wall Street Journal his patients were also impacted.